.jpg)
The Hybrid Oxygenation Bioelectronics system for Implanted Therapy, or HOBIT
Photos Credit: Jared Jones/Rice University
Scientific Frontline: Extended "At a Glance" Summary: Hybrid Oxygenation Bioelectronics system for Implanted Therapy (HOBIT)
The Core Concept: HOBIT is a fully integrated, wireless implantable device that houses engineered, drug-producing cells and sustains them by actively generating local oxygen. It solves the critical challenge of keeping dense clusters of therapeutic cells alive in poorly oxygenated areas of the body, such as under the skin.
Key Distinction/Mechanism: Unlike conventional unoxygenated cell encapsulation methods that suffer from rapid cell death due to resource competition, HOBIT utilizes a miniaturized electrocatalytic oxygenator. Powered by an onboard battery, an iridium oxide-based surface splits water from the surrounding tissue to generate oxygen directly without harmful byproducts. This active oxygenation safely supports cell densities roughly six times higher than traditional approaches.
Major Frameworks/Components:
- Electrocatalytic Oxygenator: A miniaturized system utilizing an iridium oxide surface to safely split tissue water into oxygen.
- Wireless Bioelectronics: An integrated, battery-powered electronic system allowing for the remote modulation of oxygen production.
- Two-Stage Encapsulation: Engineered cells are shielded from the host immune system by being microencapsulated in alginate hydrogel beads, which are then loaded into a larger semipermeable membrane chamber that allows nutrient and drug flow.
- Multiplexed Biologic Production: The system is proven to support cells engineered to simultaneously and continuously produce multiple therapeutic molecules of varying half-lives (e.g., an antibody, a hormone, and a GLP-1-like molecule).



.jpg)

.jpg)



.jpg)


.jpg)